Chargement…
Toutes les entreprises d’ici passées par les mêmes cinq vérifications sur la croissance et la génération de trésorerie. Cela décrit le sous-secteur tel qu’il publie aujourd’hui — pas laquelle de ces valeurs acheter.
| VRTX | VERTEX PHARMACEUTICALS INC / MA | B+ | 136,5B $US | 538,53 $US | 34,68 | 13B $US | 30,7 % |
| REGN | REGENERON PHARMACEUTICALS, INC. | C+ | 100,9B $US | 955,80 $US | 21,10 | 16,9B $US | 28,5 % |
| MRNA | Moderna, Inc. | C- | 90,3B $US | 223,22 $US | — | 2,5B $US | -110,5 % |
| ARGX | ARGENX SE | non notée | 59,4B $US | 959,78 $US | 49,04 | — | — |
| ONC | BEONE MEDICINES LTD. | A+ | 47,6B $US | 416,41 $US | 53,39 | 6,6B $US | 13,9 % |
| RPRX | Royalty Pharma plc | C+ | 39,8B $US | 69,30 $US | 45,29 | 2,6B $US | 25,7 % |
| RVMD | Revolution Medicines, Inc. | F | 37,3B $US | 172,27 $US | — | 0,00 $US | — |
| ROIV | ROIVANT SCIENCES LTD. | B- | 28,6B $US | 39,54 $US | — | 41,1M $US | -838,2 % |
| INSM | INSMED INC | C- | 26,6B $US | 121,15 $US | — | 1,5B $US | -39,9 % |
| INCY | INCYTE CORPORATION | C | 24,7B $US | 120,94 $US | 64,33 | 6B $US | 6,7 % |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | B+ | 22,1B $US | 165,05 $US | 70,84 | 3,7B $US | 71,3 % |
| BNTX | BioNTech SE | F | 21,5B $US | 85,57 $US | — | 2,7B $US | -60,9 % |
| NCNA | NUCANA PLC | non notée | 18,5B $US | 0,89 $US | — | — | — |
| ASND | Ascendis Pharma A/S | D | 17,1B $US | 275,33 $US | — | 1,3B $US | -19,0 % |
| EXEL | EXELIXIS, INC. | A+ | 16,8B $US | 68,99 $US | 20,66 | 2,5B $US | 35,5 % |
| JAZZ | Jazz Pharmaceuticals plc | A | 15,5B $US | 241,38 $US | 78,63 | 4,7B $US | 4,4 % |
| BBIO | BridgeBio Pharma, Inc. | B | 15,3B $US | 78,31 $US | — | 945,5M $US | -60,7 % |
| AKTX | Akari Therapeutics, Plc | non notée | 12,7B $US | 6,85 $US | — | — | — |
| TECH | BIO-TECHNE Corp | A+ | 11,4B $US | 72,80 $US | 66,79 | 1,2B $US | 14,0 % |
| HALO | HALOZYME THERAPEUTICS, INC. | A+ | 11,4B $US | 100,30 $US | 25,01 | 1,8B $US | 26,9 % |
| SMMT | Summit Therapeutics Inc. | non notée | 11,3B $US | 14,14 $US | — | — | — |
| BMRN | BioMarin Pharmaceutical Inc | B | 11,1B $US | 57,22 $US | — | 3,7B $US | -0,5 % |
| KYMR | KYMERA THERAPEUTICS, INC. | F- | 10,9B $US | 127,63 $US | — | 102,2M $US | -341,8 % |
| PCVX | VAXCYTE, INC. | non notée | 10B $US | 63,36 $US | — | — | — |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | B- | 9,9B $US | 427,50 $US | — | 1,4B $US | -10,9 % |
| SYRE | SPYRE THERAPEUTICS, INC. | D | 9,9B $US | 104,01 $US | — | 0,00 $US | — |
| TGTX | TG THERAPEUTICS, INC. | A+ | 9,7B $US | 64,49 $US | 96,25 | 897,8M $US | 11,8 % |
| PRAX | PRAXIS PRECISION MEDICINES, INC. | F | 9,2B $US | 327,93 $US | — | 0,00 $US | — |
| KRYS | Krystal Biotech, Inc. | A+ | 9B $US | 304,96 $US | 41,38 | 470M $US | 47,9 % |
| PTGX | PROTAGONIST THERAPEUTICS, INC. | A+ | 8,5B $US | 130,83 $US | 27,78 | 551,7M $US | 62,0 % |
| CORT | CORCEPT THERAPEUTICS INC | A+ | 8B $US | 72,94 $US | 57,43 | 963,6M $US | 16,8 % |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | C- | 8B $US | 115,03 $US | — | 280,7M $US | -69,0 % |
| CYTK | CYTOKINETICS, INCORPORATED | D | 7,8B $US | 56,14 $US | — | 113,3M $US | -686,6 % |
| AXSM | AXSOME THERAPEUTICS, INC. | B- | 7,4B $US | 141,54 $US | — | 865,3M $US | -18,2 % |
| KOD | KODIAK SCIENCES INC. | non notée | 7,3B $US | 111,19 $US | — | — | — |
| ORKA | Oruka Therapeutics, Inc. | non notée | 7,1B $US | 105,34 $US | — | — | — |
| IMVT | Immunovant, Inc. | non notée | 7,1B $US | 34,19 $US | — | — | — |
| TWST | Twist Bioscience Corporation | C- | 7B $US | 111,56 $US | — | 459,4M $US | -28,3 % |
| ABVX | Abivax S.A. | non notée | 6,9B $US | 87,63 $US | — | — | — |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | F- | 6,8B $US | 47,77 $US | — | 450,8M $US | -160,6 % |
| CGON | CG Oncology, Inc. | F- | 6,6B $US | 74,35 $US | — | 6,2M $US | -3 851,1 % |
| CAI | CARIS LIFE SCIENCES, INC. | A | 6,6B $US | 23,05 $US | 13,89 | 1B $US | 9,2 % |
| BLTE | Belite Bio, Inc | non notée | 6,5B $US | 164,03 $US | — | — | — |
| IBRX | IMMUNITYBIO, INC. | C | 6,4B $US | 6,01 $US | — | 182,6M $US | -607,8 % |
| LGND | LIGAND PHARMACEUTICALS INCORPORATED | C | 6,2B $US | 309,05 $US | 134,37 | 253,8M $US | 20,3 % |
| MIRM | Mirum Pharmaceuticals, Inc. | D- | 6,1B $US | 94,00 $US | — | 670,8M $US | -134,8 % |
| ERAS | ERASCA, INC. | non notée | 5,5B $US | 15,65 $US | — | — | — |
| MANE | Veradermics, Inc | non notée | 5,5B $US | 129,60 $US | — | — | — |
| PTCT | PTC Therapeutics, Inc. | D | 5,3B $US | 63,49 $US | — | 1,2B $US | -9,2 % |
| SRRK | SCHOLAR ROCK HOLDING CORPORATION | F- | 5,3B $US | 43,16 $US | — | 570K $US | -72 563,2 % |
| DNTH | Dianthus Therapeutics, Inc. | F- | 5,2B $US | 91,76 $US | — | 2M $US | -9 927,5 % |
| EWTX | Edgewise Therapeutics, Inc. | non notée | 5B $US | 45,97 $US | 5,62 | — | — |
| COGT | Cogent Biosciences, Inc. | non notée | 5B $US | 28,53 $US | — | — | — |
| TVTX | TRAVERE THERAPEUTICS, INC. | F- | 4,9B $US | 50,63 $US | — | 651M $US | -18,7 % |
| IONS | IONIS PHARMACEUTICALS, INC. | F- | 4,8B $US | 29,06 $US | — | 960,1M $US | -56,9 % |
| DFTX | Definium Therapeutics, Inc. | non notée | 4,4B $US | 32,09 $US | — | — | — |
| TNGX | TANGO THERAPEUTICS, INC. | F | 4,3B $US | 25,52 $US | — | 0,00 $US | — |
| GPCR | Structure Therapeutics Inc. | non notée | 4,3B $US | 20,01 $US | — | — | — |
| CRSP | CRISPR THERAPEUTICS AG | F- | 4,1B $US | 42,21 $US | — | 25,2M $US | -1 812,1 % |
| ZLAB | ZAI LAB LIMITED | F- | 4B $US | 24,61 $US | — | 441,7M $US | -44,9 % |
| RLAY | RELAY THERAPEUTICS, INC. | D- | 4B $US | 18,10 $US | — | 10,4M $US | -2 837,0 % |
| XENE | Xenon Pharmaceuticals Inc. | F | 4B $US | 40,49 $US | — | 0,00 $US | — |
| TARS | TARSUS PHARMACEUTICALS, INC. | B- | 4B $US | 80,25 $US | — | 682,2M $US | -102,9 % |
| ABCL | AbCellera Biologics Inc. | C- | 3,8B $US | 11,49 $US | — | 67,9M $US | -218,5 % |
| VKTX | VIKING THERAPEUTICS, INC. | F | 3,7B $US | 29,25 $US | — | 0,00 $US | — |
| IRON | Disc Medicine, Inc. | non notée | 3,6B $US | 80,00 $US | — | — | — |
| ELVN | ENLIVEN THERAPEUTICS, INC. | non notée | 3,6B $US | 48,77 $US | — | — | — |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | B- | 3,6B $US | 7,75 $US | — | 379M $US | -58,2 % |
| ARQT | ARCUTIS BIOTHERAPEUTICS, INC. | B | 3,6B $US | 28,25 $US | 134,52 | 508,7M $US | 5,9 % |
| PBLS | Parabilis Medicines, Inc. | non notée | 3,6B $US | 28,44 $US | — | — | — |
| VRDN | Viridian Therapeutics, Inc./DE | F- | 3,5B $US | 30,86 $US | — | 26,3M $US | -1 724,1 % |
| DBVT | DBV TECHNOLOGIES S.A. | F- | 3,5B $US | 11,07 $US | — | 3,8M $US | -5 405,3 % |
| ACAD | ACADIA PHARMACEUTICALS INC. | B+ | 3,2B $US | 18,73 $US | 8,83 | 1,2B $US | 30,1 % |
| LEGN | Legend Biotech Corp | C- | 3,2B $US | 17,49 $US | — | 1,1B $US | -22,0 % |
| GMAB | Genmab A/S | B+ | 3,2B $US | 51,36 $US | 3,34 | 3,9B $US | 21,0 % |
| DYN | Dyne Therapeutics, Inc. | non notée | 3,2B $US | 17,17 $US | — | — | — |
| CELC | CELCUITY INC. | non notée | 3,2B $US | 64,32 $US | — | — | — |
| TLX | Telix Pharmaceuticals Limited | D | 3,1B $US | 9,23 $US | — | 890,8M $US | 3,8 % |
| IDYA | IDEAYA Biosciences, Inc. | F- | 3,1B $US | 31,82 $US | — | 36,5M $US | -1 149,6 % |
| ADMA | ADMA BIOLOGICS, INC. | B+ | 3B $US | 13,69 $US | 17,78 | 519,2M $US | 35,1 % |
| DNLI | Denali Therapeutics Inc. | F | 3B $US | 18,74 $US | — | 0,00 $US | — |
| VCEL | VERICEL CORPORATION | A | 2,9B $US | 56,96 $US | 89,00 | 324,2M $US | 10,3 % |
| XNCR | Xencor, Inc | D- | 2,8B $US | 37,08 $US | — | 200,5M $US | -58,8 % |
| MBX | MBX Biosciences, Inc. | non notée | 2,8B $US | 55,98 $US | — | — | — |
| RCUS | Arcus Biosciences, Inc. | F- | 2,5B $US | 17,43 $US | — | 100M $US | -453,0 % |
| NAMS | NewAmsterdam Pharma Company N.V. | D- | 2,4B $US | 20,16 $US | — | 25,9M $US | -789,9 % |
| BEAM | Beam Therapeutics Inc. | F- | 2,4B $US | 22,82 $US | — | 146,6M $US | -73,9 % |
| CLDX | Celldex Therapeutics, Inc. | F- | 2,3B $US | 28,82 $US | — | 158K $US | -195 608,9 % |
| LKFT | GALAPAGOS NV | D | 2,2B $US | 33,95 $US | 6,31 | 1,2B $US | 28,9 % |
| PVLA | Palvella Therapeutics, Inc. | non notée | 2,2B $US | 152,51 $US | — | — | — |
| IMNM | Immunome Inc. | F | 2,2B $US | 18,74 $US | — | 0,00 $US | — |
| PHVS | Pharvaris N.V. | non notée | 2,2B $US | 33,37 $US | — | — | — |
| AUPH | Aurinia Pharmaceuticals Inc. | A+ | 2,1B $US | 15,73 $US | 6,87 | 321,7M $US | 97,7 % |
| BHVN | Biohaven Ltd. | non notée | 2,1B $US | 13,81 $US | — | — | — |
| REPL | REPLIMUNE GROUP, INC. | non notée | 2,1B $US | 21,90 $US | — | — | — |
| VERA | Vera Therapeutics, Inc. | non notée | 2B $US | 28,11 $US | — | — | — |
| SEPN | Septerna, Inc. | F- | 2B $US | 42,61 $US | — | 96,3M $US | -61,3 % |
| HRMY | HARMONY BIOSCIENCES HOLDINGS, INC. | B+ | 2B $US | 33,76 $US | 11,14 | 989,4M $US | 18,1 % |
| TRAX | FIRST TRACKS BIOTHERAPEUTICS, INC. | non notée | 2B $US | 47,15 $US | — | — | — |
| RXRX | RECURSION PHARMACEUTICALS, INC. | D- | 2B $US | 3,18 $US | — | 68,2M $US | -697,1 % |
| MRVI | Maravai LifeSciences Holdings, Inc. | D- | 2B $US | 7,54 $US | — | 213M $US | -30,8 % |
| FTRE | Fortrea Holdings Inc. | C | 1,9B $US | 20,20 $US | — | 2,7B $US | -2,6 % |
| TRVI | TREVI THERAPEUTICS, INC. | non notée | 1,9B $US | 13,65 $US | — | — | — |
| COAG | Hemab Therapeutics Holdings, Inc. | non notée | 1,9B $US | 40,79 $US | — | — | — |
| ZBIO | Zenas BioPharma, Inc. | F- | 1,9B $US | 27,99 $US | — | 10M $US | -5 418,1 % |
| AGIO | AGIOS PHARMACEUTICALS, INC. | C- | 1,9B $US | 31,57 $US | — | 140,8M $US | -264,8 % |
| MAZE | MAZE THERAPEUTICS, INC. | non notée | 1,9B $US | 34,29 $US | — | — | — |
| ZYME | ZYMEWORKS INC. | F+ | 1,8B $US | 26,24 $US | 50,46 | 266M $US | 16,3 % |
| BRVE | Braveheart Bio, Inc. | non notée | 1,8B $US | 19,67 $US | — | — | — |
| STOK | Stoke Therapeutics, Inc. | F- | 1,7B $US | 26,66 $US | — | 28,2M $US | -862,1 % |
| SRPT | SAREPTA THERAPEUTICS, INC. | C | 1,7B $US | 16,07 $US | — | 2B $US | -5,9 % |
| KLRA | Kailera Therapeutics, Inc. | non notée | 1,7B $US | 13,26 $US | — | — | — |
| MESO | MESOBLAST LIMITED | C- | 1,7B $US | 13,25 $US | — | 65,4M $US | -144,3 % |
| VIR | Vir Biotechnology, Inc. | C- | 1,7B $US | 9,96 $US | — | 302,8M $US | -61,0 % |
| NRIX | NURIX THERAPEUTICS, INC. | A+ | 1,7B $US | 15,47 $US | 6,72 | 701,9M $US | 42,0 % |
| QURE | uniQure N.V. | F- | 1,7B $US | 23,84 $US | — | 20,2M $US | -1 154,8 % |
| RARE | ULTRAGENYX PHARMACEUTICAL INC. | C | 1,6B $US | 16,07 $US | — | 730M $US | -71,8 % |
| PGEN | PRECIGEN, INC. | C | 1,6B $US | 4,52 $US | 45,20 | 156,9M $US | 15,6 % |
| SLS | SELLAS Life Sciences Group, Inc. | non notée | 1,6B $US | 7,87 $US | — | — | — |
| GENB | Generate Biomedicines, Inc. | non notée | 1,6B $US | 12,06 $US | — | — | — |
| RAPP | Rapport Therapeutics, Inc. | non notée | 1,6B $US | 26,16 $US | — | — | — |
| IMCR | Immunocore Holdings plc | F- | 1,5B $US | 29,99 $US | — | 429,3M $US | -7,5 % |
| NBTX | Nanobiotix S.A. | C- | 1,5B $US | 30,34 $US | — | 36,4M $US | -73,5 % |
| ABSI | ABSCI CORP | F- | 1,5B $US | 8,45 $US | — | 1,5M $US | -8 451,3 % |
| NUVB | Nuvation Bio Inc. | C- | 1,4B $US | 3,99 $US | — | 201,7M $US | -67,4 % |
| NVAX | NOVAVAX, INC. | F | 1,4B $US | 8,53 $US | — | 411,6M $US | -18,6 % |
| LBRX | LB Pharmaceuticals Inc | non notée | 1,4B $US | 42,93 $US | — | — | — |
| TYRA | TYRA BIOSCIENCES, INC. | non notée | 1,4B $US | 20,03 $US | — | — | — |
| ANAB | ANAPTYSBIO, INC. | D+ | 1,4B $US | 46,26 $US | 8,68 | 191,6M $US | 96,3 % |
| AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | D- | 1,4B $US | 14,71 $US | — | 96,6M $US | -193,4 % |
| OCUL | OCULAR THERAPEUTIX, INC | F- | 1,4B $US | 6,20 $US | — | 50,4M $US | -648,6 % |
| NTLA | INTELLIA THERAPEUTICS, INC. | D- | 1,4B $US | 9,70 $US | — | 52,9M $US | -805,7 % |
| MLYS | MINERALYS THERAPEUTICS, INC. | non notée | 1,4B $US | 15,32 $US | — | — | — |
| INVA | INNOVIVA, INC. | C+ | 1,4B $US | 19,03 $US | 9,51 | 438,3M $US | 44,1 % |
| AVLN | Avalyn Pharma Inc. | non notée | 1,3B $US | 30,26 $US | — | — | — |
| DMRA | DAMORA THERAPEUTICS, INC. | non notée | 1,3B $US | 21,61 $US | — | — | — |
| TSHA | Taysha Gene Therapies, Inc. | F- | 1,3B $US | 4,09 $US | — | 5,5M $US | -2 844,6 % |
| MNKD | MannKind Corporation | D | 1,3B $US | 4,12 $US | — | 413,4M $US | -18,1 % |
| KARD | Kardigan, Inc. | non notée | 1,3B $US | 13,83 $US | — | — | — |
| URGN | UroGen Pharma Ltd. | C | 1,3B $US | 26,18 $US | — | 250,3M $US | -26,3 % |
| NKTR | NEKTAR THERAPEUTICS | F- | 1,3B $US | 37,29 $US | — | 52,2M $US | -339,7 % |
| OMER | OMEROS CORP | non notée | 1,3B $US | 17,49 $US | 10,17 | — | — |
| SLN | Silence Therapeutics plc | F- | 1,2B $US | 19,84 $US | — | 456K $US | -11 276,5 % |
| INBX | Inhibrx Biosciences, Inc. | D- | 1,2B $US | 83,17 $US | — | 1,3M $US | -10 896,8 % |
| VOR | Vor Biopharma Inc. | non notée | 1,2B $US | 19,42 $US | 0,06 | — | — |
| ANRO | Alto Neuroscience, Inc. | non notée | 1,2B $US | 29,66 $US | — | — | — |
| GHRS | GH Research PLC | non notée | 1,2B $US | 19,17 $US | — | — | — |
| DRTS | Alpha Tau Medical Ltd. | non notée | 1,2B $US | 13,37 $US | — | — | — |
| JBIO | Jade Biosciences, Inc. | non notée | 1,1B $US | 16,13 $US | — | — | — |
| SGP | SpyGlass Pharma, Inc. | non notée | 1,1B $US | 32,93 $US | — | — | — |
| SPTX | Seaport Therapeutics, Inc. | non notée | 1,1B $US | 19,93 $US | — | — | — |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | non notée | 1,1B $US | 12,51 $US | — | — | — |
| VSTM | Verastem, Inc. | F- | 1B $US | 8,19 $US | — | 100,3M $US | -178,4 % |
| SVRA | Savara Inc. | non notée | 1B $US | 4,64 $US | — | — | — |
| AKTS | Aktis Oncology, Inc. | non notée | 928,5M $US | 16,64 $US | — | — | — |
| ODTX | Odyssey Therapeutics, Inc. | non notée | 918,1M $US | 19,10 $US | — | — | — |
| PHAR | Pharming Group N.V. | A | 912,9M $US | 13,01 $US | 325,25 | 376,1M $US | 0,8 % |
| MGTX | MeiraGTx Holdings plc | B | 898,6M $US | 9,20 $US | 11,49 | 401,9M $US | 19,5 % |
| CRVS | Corvus Pharmaceuticals, Inc. | non notée | 896,7M $US | 10,63 $US | — | — | — |
| FDMT | 4D Molecular Therapeutics, Inc. | C- | 884,5M $US | 12,22 $US | — | 96,1M $US | -208,6 % |
| LTGO | Latigo Biotherapeutics, Inc. | non notée | 872,2M $US | 13,16 $US | — | — | — |
| IMTX | Immatics N.V. | non notée | 857,4M $US | 6,40 $US | — | — | — |
| SNDX | Syndax Pharmaceuticals, Inc. | D- | 843M $US | 9,44 $US | — | 289,7M $US | -72,3 % |
| RIGL | RIGEL PHARMACEUTICALS INC | B+ | 838,9M $US | 44,55 $US | 2,77 | 288,2M $US | 106,6 % |
| ORIC | ORIC PHARMACEUTICALS, INC. | non notée | 811,6M $US | 7,83 $US | — | — | — |
| ANNX | ANNEXON, INC. | non notée | 807,7M $US | 3,93 $US | — | — | — |
| LXRX | Lexicon Pharmaceuticals, Inc. | D- | 801,4M $US | 1,80 $US | — | 38,5M $US | -161,8 % |
| GLUE | Monte Rosa Therapeutics, Inc. | F- | 800,7M $US | 9,37 $US | — | 70,3M $US | -186,2 % |
| OBX | OBSIDIAN THERAPEUTICS, INC. | F | 777,1M $US | 12,58 $US | — | 0,00 $US | — |
| ARDX | ARDELYX, INC. | C- | 774,2M $US | 3,08 $US | — | 468,2M $US | -11,8 % |
| PRME | Prime Medicine, Inc. | B- | 774,1M $US | 4,26 $US | — | 4,6M $US | -3 807,3 % |
| SLDB | Solid Biosciences Inc. | non notée | 763,4M $US | 6,84 $US | — | — | — |
| ACHV | Achieve Life Sciences, Inc. | non notée | 747,1M $US | 6,79 $US | — | — | — |
| AURA | AURA BIOSCIENCES, INC. | non notée | 740M $US | 7,11 $US | — | — | — |
| SGMT | Sagimet Biosciences Inc. | non notée | 729,4M $US | 10,22 $US | — | — | — |
| ALMS | Alumis Inc. | F- | 725,7M $US | 5,59 $US | — | 7,2M $US | -5 844,5 % |
| OABI | OMNIAB, INC. | B | 715,4M $US | 4,91 $US | — | 40,2M $US | -108,1 % |
| KURA | Kura Oncology, Inc. | C- | 713,4M $US | 7,77 $US | — | 79,3M $US | -369,3 % |
| IVA | Inventiva S.A. | F | 711,1M $US | 3,68 $US | — | 5M $US | -7 899,6 % |
| APMD | Apnimed, Inc. | non notée | 705,4M $US | 16,95 $US | — | — | — |
| NVCT | NUVECTIS PHARMA, INC. | non notée | 697,4M $US | 20,28 $US | — | — | — |
| JANX | Janux Therapeutics, Inc. | C- | 695M $US | 11,36 $US | — | 23,3M $US | -428,7 % |
| ATTO | Attovia Therapeutics, Inc. | non notée | 693,9M $US | 15,18 $US | — | — | — |
| AVBP | ARRIVENT BIOPHARMA, INC. | non notée | 673,4M $US | 13,02 $US | — | — | — |
| DSGN | Design Therapeutics, Inc. | F | 670,8M $US | 10,48 $US | — | 0,00 $US | — |
| CGEM | CULLINAN THERAPEUTICS, INC. | non notée | 667,1M $US | 10,28 $US | — | — | — |
| BCAX | BICARA THERAPEUTICS INC. | non notée | 665,9M $US | 10,03 $US | — | — | — |
| OLMA | OLEMA PHARMACEUTICALS, INC. | non notée | 660,6M $US | 7,54 $US | — | — | — |
| IMMX | IMMIX BIOPHARMA, INC. | non notée | 656,3M $US | 7,83 $US | — | — | — |
| ABUS | ARBUTUS BIOPHARMA CORP | D+ | 627M $US | 4,09 $US | 3,62 | 181,5M $US | 121,2 % |
| DNA | GINKGO BIOWORKS HOLDINGS, INC. | F- | 623M $US | 9,61 $US | — | 130,8M $US | -192,0 % |
| ACRS | Aclaris Therapeutics, Inc. | F- | 621,8M $US | 3,92 $US | — | 6,4M $US | -1 244,1 % |
| GERN | GERON CORP | non notée | 618,5M $US | 0,96 $US | — | — | — |
| WVE | WAVE LIFE SCIENCES, INC. | F- | 618,3M $US | 3,14 $US | — | 70,9M $US | -296,9 % |
| CLYM | Climb Bio, Inc. | non notée | 607,9M $US | 10,35 $US | — | — | — |
| SANA | Sana Biotechnology, Inc. | non notée | 603,8M $US | 2,02 $US | — | — | — |
| OBIO | Orchestra BioMed Holdings, Inc. | F- | 569M $US | 7,23 $US | — | 31,2M $US | -182,5 % |
| CAPR | CAPRICOR THERAPEUTICS, INC. | F- | 553,8M $US | 9,53 $US | — | 0,00 $US | — |
| CBIO | Crescent Biopharma, Inc. | D- | 553,5M $US | 14,23 $US | — | 15M $US | -727,6 % |
| ENTX | ENTERA BIO LTD. | F | 545,1M $US | 3,13 $US | — | 0,00 $US | — |
| ZVRA | Zevra Therapeutics, Inc. | B+ | 539,1M $US | 9,06 $US | 7,61 | 147,8M $US | 52,8 % |
| RGNX | REGENXBIO Inc. | F- | 505,2M $US | 7,64 $US | — | 153,9M $US | -113,9 % |
| GYRE | Gyre Therapeutics, Inc. | F- | 495,9M $US | 4,30 $US | — | 108,1M $US | -33,9 % |
| NGNE | Neurogene Inc. | F | 495M $US | 23,91 $US | — | 0,00 $US | — |
| PHAT | PHATHOM PHARMACEUTICALS, INC. | B | 494,3M $US | 6,08 $US | — | 274,9M $US | -30,2 % |
| VALN | Valneva SE | F- | 491,1M $US | 5,66 $US | — | 174,7M $US | -73,7 % |
| MNPR | Monopar Therapeutics Inc. | F | 488,4M $US | 72,07 $US | — | 0,00 $US | — |
| CADL | CANDEL THERAPEUTICS, INC. | non notée | 486,4M $US | 6,20 $US | — | — | — |
| INDP | Indaptus Therapeutics, Inc. | non notée | 485,4M $US | 3,16 $US | — | — | — |
| DMAC | DIAMEDICA THERAPEUTICS INC. | non notée | 475,1M $US | 8,81 $US | — | — | — |
| STTK | Shattuck Labs, Inc. | F | 472,5M $US | 4,64 $US | — | 0,00 $US | — |
| MDXG | MIMEDX GROUP, INC. | F | 468,4M $US | 3,21 $US | — | 303,7M $US | -6,3 % |
| JSPR | Jasper Therapeutics, Inc. | non notée | 454,9M $US | 13,67 $US | — | — | — |
| RLMD | RELMADA THERAPEUTICS, INC. | non notée | 450,3M $US | 4,22 $US | — | — | — |
| AVTX | AVALO THERAPEUTICS, INC. | F- | 448,1M $US | 7,75 $US | — | 59K $US | -150 259,3 % |
| BLSM | BlossomHill Therapeutics, Inc. | non notée | 447,2M $US | 14,07 $US | — | — | — |
| ARVN | ARVINAS, INC. | C- | 446,6M $US | 6,82 $US | — | 275,3M $US | -3,5 % |
| CTMX | CytomX Therapeutics, Inc. | F- | 443,6M $US | 2,04 $US | — | 14M $US | -609,0 % |
| ASMB | ASSEMBLY BIOSCIENCES, INC. | C- | 433,1M $US | 21,15 $US | — | 72,3M $US | -15,4 % |
| IRLA | IRulya Therapeutics Inc. | non notée | 431,3M $US | 39,78 $US | — | — | — |
| KRSA | Korsana Biosciences, Inc. | F | 426,1M $US | 31,50 $US | — | 1,9M $US | -3 098,7 % |
| TECX | TECTONIC THERAPEUTIC, INC. | non notée | 419,7M $US | 21,04 $US | — | — | — |
| PRTA | PROTHENA CORPORATION PUBLIC LIMITED COMPANY | D- | 419,5M $US | 8,17 $US | — | 52,7M $US | -45,4 % |
| FENC | FENNEC PHARMACEUTICALS INC. | A | 411,1M $US | 11,65 $US | 582,25 | 66,4M $US | 3,1 % |
| OCS | Oculis Holding AG | non notée | 401,2M $US | 7,68 $US | — | — | — |
| PBYI | PUMA BIOTECHNOLOGY, INC. | B+ | 401,2M $US | 7,76 $US | 16,87 | 231,8M $US | 10,3 % |
| SPRY | ARS Pharmaceuticals, Inc. | F- | 392,1M $US | 3,90 $US | — | 122,1M $US | -163,6 % |
| IRD | Opus Genetics, Inc. | F- | 385,7M $US | 3,99 $US | — | 7,9M $US | -1 726,7 % |
| ALEC | Alector, Inc. | B+ | 379,6M $US | 2,55 $US | 7,29 | 173,5M $US | 23,9 % |
| CNTN | CANTON STRATEGIC HOLDINGS, INC. | non notée | 371,9M $US | 1,72 $US | — | — | — |
| CRMD | CORMEDIX INC. | B+ | 370,2M $US | 4,66 $US | 7,76 | 412,5M $US | 15,5 % |
| CCCC | C4 Therapeutics, Inc. | D- | 363,1M $US | 2,77 $US | — | 32,3M $US | -282,2 % |
| RZLT | Rezolute, Inc. | non notée | 353,1M $US | 3,65 $US | — | — | — |
| LYEL | Lyell Immunopharma, Inc. | F- | 350,6M $US | 14,26 $US | — | 15K $US | -1 701 066,7 % |
| AVIR | Atea Pharmaceuticals, Inc. | non notée | 345,3M $US | 4,30 $US | — | — | — |
| YDES | YD Bio Limited | D | 345,1M $US | 4,88 $US | — | 596,8K $US | -1 392,6 % |
| ANL | Adlai Nortye Ltd. | C | 341,2M $US | 10,67 $US | — | 5M $US | -710,6 % |
| EDIT | EDITAS MEDICINE, INC. | B- | 334,1M $US | 2,17 $US | — | 49,8M $US | -145,0 % |
| EPRX | EUPRAXIA PHARMACEUTICALS INC. | F | 326M $US | 8,16 $US | — | 0,00 $US | — |
| BNTC | BENITEC BIOPHARMA INC. | D | 325,8M $US | 9,02 $US | — | 0,00 $US | — |
| IMUX | Immunic, Inc. | non notée | 323,5M $US | 7,56 $US | — | — | — |
| EIKN | EIKON THERAPEUTICS, INC. | non notée | 322,9M $US | 5,96 $US | — | — | — |
| ENTA | ENANTA PHARMACEUTICALS, INC | F- | 319,8M $US | 10,98 $US | — | 65,3M $US | -96,9 % |
| KYTX | Kyverna Therapeutics, Inc. | non notée | 319,3M $US | 5,05 $US | — | — | — |
| ALT | ALTIMMUNE, INC. | D- | 319,1M $US | 1,64 $US | — | 41K $US | -254 522,0 % |
| XFOR | X4 PHARMACEUTICALS, INC | D- | 318,6M $US | 3,12 $US | — | 17M $US | -474,7 % |
| EVMN | Evommune, Inc. | F | 315,5M $US | 7,63 $US | — | 0,00 $US | — |
| PROK | ProKidney Corp. | F- | 314,5M $US | 1,04 $US | — | 775K $US | -13 326,7 % |
| LRMR | LARIMAR THERAPEUTICS, INC. | non notée | 312,7M $US | 3,01 $US | — | — | — |
| SCTX | SCRIBE THERAPEUTICS INC. | non notée | 310,2M $US | 16,38 $US | — | — | — |
| AUTL | AUTOLUS THERAPEUTICS PLC | C- | 309M $US | 1,16 $US | — | 137,4M $US | -186,4 % |
| VERU | VERU INC. | non notée | 308,9M $US | 2,11 $US | — | — | — |
| GALT | GALECTIN THERAPEUTICS INC. | non notée | 308,6M $US | 3,06 $US | — | — | — |
| HELP | CYBIN INC. | non notée | 308M $US | 8,85 $US | — | — | — |
| MPLT | MapLight Therapeutics, Inc. | non notée | 307,7M $US | 7,25 $US | — | — | — |
| AGEN | AGENUS INC | D | 304,1M $US | 6,72 $US | 10,18 | 133,9M $US | 23,0 % |
| IPSC | Century Therapeutics, Inc. | C- | 301,5M $US | 1,66 $US | — | 109,2M $US | -90,5 % |
| PEPG | PEPGEN INC. | non notée | 301,3M $US | 4,35 $US | — | — | — |
| NAUT | NAUTILUS BIOTECHNOLOGY, INC. | non notée | 295,5M $US | 2,32 $US | — | — | — |
| ALLO | Allogene Therapeutics, Inc. | C- | 290,7M $US | 0,84 $US | — | 6,9M $US | -2 513,9 % |
| FULC | FULCRUM THERAPEUTICS, INC. | F- | 288M $US | 3,77 $US | — | 0,00 $US | — |
| TTRX | Turn Therapeutics Inc. | non notée | 285,9M $US | 9,35 $US | — | — | — |
| OCGN | OCUGEN, INC. | F | 280,9M $US | 0,83 $US | — | 4,8M $US | -1 367,6 % |
| CABA | CABALETTA BIO, INC. | non notée | 276,1M $US | 1,28 $US | — | — | — |
| PRLD | PRELUDE THERAPEUTICS INC | B- | 275,7M $US | 3,46 $US | — | 22,4M $US | -269,7 % |
| YARW | YARROW BIOSCIENCE, INC. | D | 274,1M $US | 17,99 $US | — | 482K $US | -3 881,5 % |
| INO | INOVIO PHARMACEUTICALS, INC. | C- | 268,8M $US | 1,44 $US | — | 298,9K $US | -23 798,9 % |
| SABS | SAB BIOTHERAPEUTICS, INC. | F- | 267,6M $US | 2,97 $US | — | 0,00 $US | — |
| QTTB | Q32 Bio Inc. | B | 261,4M $US | 8,74 $US | 2,52 | 53,7M $US | 60,0 % |
| FTH | Faeth Therapeutics, Inc. | non notée | 259,9M $US | 10,06 $US | — | — | — |
| PLX | PROTALIX BIOTHERAPEUTICS, INC. | A+ | 257,2M $US | 3,05 $US | 12,20 | 84,7M $US | 24,3 % |
| RCKT | Rocket Pharmaceuticals, Inc. | D | 255,1M $US | 2,29 $US | — | 0,00 $US | — |
| VOGX | Vogenx, Inc. | non notée | 252,1M $US | 16,97 $US | — | — | — |
| CUVL | CLINUVEL PHARMACEUTICALS LIMITED | C+ | 250,6M $US | 4,97 $US | 10,80 | 64,3M $US | 36,0 % |
| VNDA | VANDA PHARMACEUTICALS INC. | F- | 241,9M $US | 4,00 $US | — | 229,3M $US | -119,9 % |
| ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC. | F- | 240,4M $US | 8,34 $US | — | 30,5M $US | -285,9 % |
| IMRX | Immuneering Corporation | non notée | 240,1M $US | 3,71 $US | — | — | — |
| CAMP | CAMP4 Therapeutics Corporation | B- | 236,6M $US | 3,77 $US | — | 5,3M $US | -2 276,3 % |
| LXEO | Lexeo Therapeutics, Inc. | non notée | 235,5M $US | 2,87 $US | — | — | — |
| BCYC | Bicycle Therapeutics plc | C- | 234,4M $US | 3,35 $US | — | 83,5M $US | -169,8 % |
| LCTX | Lineage Cell Therapeutics, Inc. | F | 229,4M $US | 0,91 $US | — | 10,8M $US | 16,2 % |
| CTNM | Contineum Therapeutics, Inc. | non notée | 227,8M $US | 9,86 $US | — | — | — |
| ADRX | ADARx Pharmaceuticals, Inc. | non notée | 227,6M $US | 14,11 $US | — | — | — |
| GLSI | GREENWICH LIFESCIENCES, INC. | non notée | 219,2M $US | 14,94 $US | — | — | — |
| ACIU | AC IMMUNE SA | D- | 216,2M $US | 2,13 $US | — | 4,5M $US | -1 903,0 % |
| IKT | INHIBIKASE THERAPEUTICS, INC. | F | 213,2M $US | 1,52 $US | — | 0,00 $US | — |
| DTIL | PRECISION BIOSCIENCES INC | D- | 211,3M $US | 7,57 $US | — | 45M $US | -85,6 % |
| KROS | KEROS THERAPEUTICS, INC. | F- | 202,7M $US | 10,33 $US | — | 40,8M $US | -151,4 % |
| PALI | PALISADE BIO, INC. | F- | 199,9M $US | 1,12 $US | — | 500K $US | -8 739,2 % |
| TRDA | ENTRADA THERAPEUTICS, INC. | F- | 198,9M $US | 5,08 $US | — | 4M $US | -4 058,0 % |
| CGEN | COMPUGEN LTD | B+ | 198,6M $US | 2,10 $US | 5,53 | 75,9M $US | 47,9 % |
| ARTV | Artiva Biotherapeutics, Inc. | F- | 198,2M $US | 4,01 $US | — | 0,00 $US | — |
| ALPS | ALPS GROUP INC | non notée | 198M $US | 1,19 $US | — | — | — |
| LIMN | LIMINATUS PHARMA, INC. | non notée | 196,1M $US | 2,92 $US | — | — | — |
| RNAC | Cartesian Therapeutics, Inc. | F | 193,7M $US | 6,35 $US | — | 1M $US | -12 435,2 % |
| PYXS | Pyxis Oncology, Inc. | D- | 189M $US | 1,58 $US | — | 13,9M $US | -625,7 % |
| KRRO | Korro Bio, Inc. | D- | 186,3M $US | 13,57 $US | — | 1,3M $US | -8 214,5 % |
| ACOG | Alpha Cognition Inc. | D- | 184,4M $US | 8,37 $US | — | 20,2M $US | -144,6 % |
| OVID | Ovid Therapeutics Inc. | D- | 181M $US | 2,55 $US | — | 1,5M $US | -2 971,3 % |
| WHWK | WHITEHAWK THERAPEUTICS, INC. | F | 180,6M $US | 3,06 $US | — | 0,00 $US | — |
| ELDN | ELEDON PHARMACEUTICALS, INC. | non notée | 178,2M $US | 2,11 $US | — | — | — |
| ANTX | AN2 Therapeutics, Inc. | non notée | 173,4M $US | 4,57 $US | — | — | — |
| IVVD | INVIVYD, INC. | D- | 171,8M $US | 0,58 $US | — | 58,4M $US | -183,9 % |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. | non notée | 171,3M $US | 2,14 $US | — | — | — |
| ZNTL | Zentalis Pharmaceuticals, Inc. | F | 167,1M $US | 1,70 $US | — | 0,00 $US | — |
| MDWD | MEDIWOUND LTD. | F- | 165,3M $US | 12,88 $US | — | 10M $US | -235,0 % |
| STRO | SUTRO BIOPHARMA, INC. | D | 163,2M $US | 9,83 $US | — | 45,1M $US | -344,2 % |
| GTBP | GT Biopharma, Inc. | non notée | 162,8M $US | 3,61 $US | 9,75 | — | — |
| RNA | Atrium Therapeutics, Inc. | non notée | 162M $US | 7,51 $US | — | — | — |
| ENGN | enGene Therapeutics Inc. | non notée | 161,5M $US | 2,41 $US | — | — | — |
| ORMP | ORAMED PHARMACEUTICALS INC. | C | 160,9M $US | 3,70 $US | — | 2M $US | 7 244,3 % |
| DRUG | BRIGHT MINDS BIOSCIENCES INC. | non notée | 159,2M $US | 23,15 $US | — | — | — |
| SLGL | Sol-Gel Technologies Ltd. | D | 156M $US | 56,01 $US | — | 1,4M $US | -426,7 % |
| TARA | Protara Therapeutics, Inc. | non notée | 155,5M $US | 2,53 $US | — | — | — |
| FATE | FATE THERAPEUTICS INC | F- | 155M $US | 1,28 $US | — | 4,8M $US | -2 619,6 % |
| HUMA | Humacyte, Inc. | C- | 154M $US | 0,55 $US | — | 2,4M $US | -3 955,1 % |
| UPB | UPSTREAM BIO, INC. | F- | 151,3M $US | 2,76 $US | — | 2,9M $US | -5 712,3 % |
| SION | SIONNA THERAPEUTICS, INC. | non notée | 150,6M $US | 3,33 $US | — | — | — |
| NGEN | NERVGEN PHARMA CORP. | non notée | 149,7M $US | 1,88 $US | — | — | — |
| PRQR | ProQR Therapeutics N.V. | C- | 147,5M $US | 1,40 $US | — | 22,8M $US | -204,4 % |
| ALXO | ALX ONCOLOGY HOLDINGS INC | non notée | 143,1M $US | 1,04 $US | — | — | — |
| ARMP | ARMATA PHARMACEUTICALS, INC. | non notée | 142,8M $US | 3,84 $US | — | — | — |
| MGNX | MACROGENICS, INC. | D- | 141,9M $US | 2,22 $US | — | 154,9M $US | -33,2 % |
| NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | D | 141,7M $US | 4,91 $US | — | 40K $US | -107 587,6 % |
| CMPX | COMPASS THERAPEUTICS, INC. | F | 139,2M $US | 0,77 $US | — | 0,00 $US | — |
| ABEO | ABEONA THERAPEUTICS INC. | C- | 137,7M $US | 2,41 $US | — | 39M $US | -160,3 % |
| MENS | Jyong Biotech Ltd. | non notée | 132,3M $US | 1,74 $US | — | — | — |
| IPHA | Innate Pharma SA | F- | 130,3M $US | 1,39 $US | — | 10,1M $US | -546,1 % |
| LENZ | LENZ THERAPEUTICS, INC. | F- | 129,8M $US | 4,13 $US | — | 12,4M $US | -1 135,0 % |
| CDXS | Codexis, Inc. | B- | 124,4M $US | 1,14 $US | — | 88,3M $US | -21,8 % |
| SPRB | Spruce Biosciences, Inc. | F | 123,9M $US | 43,12 $US | — | 0,00 $US | — |
| FHTX | Foghorn Therapeutics Inc. | B | 123,8M $US | 2,07 $US | 29,50 | 112,1M $US | 8,4 % |
| CLLS | Cellectis S.A. | F- | 119,8M $US | 1,20 $US | — | 25,2M $US | -506,1 % |
| ZURA | Zura Bio Limited | non notée | 119,4M $US | 1,24 $US | — | — | — |
| CUE | Cue Biopharma, Inc. | D- | 117,4M $US | 16,16 $US | — | 37,7M $US | -435,8 % |
| NERV | Minerva Neurosciences, Inc. | non notée | 115,1M $US | 2,31 $US | — | — | — |
| PYPD | PolyPid Ltd | non notée | 114,5M $US | 6,29 $US | — | — | — |
| LEXX | LEXARIA BIOSCIENCE CORP. | D- | 110,1M $US | 4,44 $US | — | 194K $US | -3 985,6 % |
| IBIO | iBio, Inc. | C- | 110M $US | 0,73 $US | — | 1,1M $US | -3 244,2 % |
| VYGR | Voyager Therapeutics, Inc. | F- | 107,3M $US | 1,73 $US | — | 25,1M $US | -416,3 % |
| OKUR | ONKURE THERAPEUTICS, INC. | non notée | 106,3M $US | 2,63 $US | — | — | — |
| EQ | Equillium, Inc. | non notée | 106,2M $US | 1,29 $US | — | — | — |
| MSLE | Satellos Bioscience Inc. | non notée | 102,5M $US | 6,63 $US | — | — | — |
| ADAG | Adagene Inc. | C- | 101M $US | 1,71 $US | — | 7,7M $US | -229,6 % |
| OTLK | OUTLOOK THERAPEUTICS, INC. | F+ | 100,6M $US | 0,41 $US | — | -1,2M $US | 5 253,5 % |
| UNCY | UNICYCIVE THERAPEUTICS, INC. | non notée | 98,9M $US | 3,55 $US | — | — | — |
| ICCC | ImmuCell Corporation | A | 97,6M $US | 10,74 $US | 56,53 | 33,2M $US | 5,7 % |
| NBP | NovaBridge Biosciences | non notée | 96,3M $US | 0,83 $US | — | — | — |
| PMVP | PMV PHARMACEUTICALS, INC. | non notée | 95,6M $US | 1,27 $US | — | — | — |
| HURA | TuHURA BIOSCIENCES, INC./NV | F | 92,1M $US | 1,40 $US | — | 0,00 $US | — |
| ANIX | ANIXA BIOSCIENCES, INC. | non notée | 91,6M $US | 2,64 $US | — | — | — |
| VANI | Vivani Medical, Inc. | F | 91,6M $US | 1,02 $US | — | 0,00 $US | — |
| PLYX | Polaryx Therapeutics, Inc. | non notée | 91,5M $US | 1,84 $US | — | — | — |
| SEER | SEER, INC. | F- | 87,6M $US | 1,57 $US | — | 14,1M $US | -450,9 % |
| AVXL | ANAVEX LIFE SCIENCES CORP. | non notée | 86,5M $US | 0,93 $US | — | — | — |
| CBUS | Cibus, Inc. | C- | 86,2M $US | 1,13 $US | — | 4,5M $US | -2 131,4 % |
| NKTX | Nkarta, Inc. | D | 85,3M $US | 1,19 $US | — | 0,00 $US | — |
| GNLX | GENELUX CORPORATION | F- | 85,1M $US | 1,88 $US | — | 8K $US | -444 950,0 % |
| RLYB | RALLYBIO CORPORATION | A | 84,9M $US | 15,76 $US | — | 434K $US | 6 177,4 % |
| IFRX | InflaRx N.V. | F- | 84,6M $US | 1,17 $US | — | 32,8K $US | -155 582,1 % |
| BDTX | BLACK DIAMOND THERAPEUTICS, INC. | F | 83,9M $US | 1,46 $US | — | 0,00 $US | — |
| LONA | LeonaBio, Inc. | non notée | 82,3M $US | 3,47 $US | — | — | — |
| CHRS | Coherus Oncology, Inc. | C | 80,7M $US | 0,52 $US | — | 53,6M $US | -253,4 % |
| NMRA | NEUMORA THERAPEUTICS, INC. | non notée | 80,6M $US | 0,43 $US | — | — | — |
| ATRA | Atara Biotherapeutics, Inc. | F | 80,5M $US | 7,90 $US | — | 4M $US | -368,6 % |
| TNYA | TENAYA THERAPEUTICS, INC. | non notée | 79,1M $US | 0,35 $US | — | — | — |
| NRXS | NEURAXIS, INC. | D- | 78M $US | 5,50 $US | — | 6,5M $US | -185,2 % |
| RANI | RANI THERAPEUTICS HOLDINGS, INC. | C- | 73,8M $US | 0,53 $US | — | 6,6M $US | -493,0 % |
| TENX | TENAX THERAPEUTICS, INC. | F | 73,8M $US | 1,62 $US | — | 0,00 $US | — |
| COYA | Coya Therapeutics, Inc. | F- | 73,2M $US | 3,12 $US | — | 4,7M $US | -643,5 % |
| NTRB | NUTRIBAND INC. | F- | 72,3M $US | 5,95 $US | — | 1,6M $US | -430,4 % |
| PMCB | PHARMACYTE BIOTECH, INC. | D | 71,7M $US | 6,68 $US | — | 0,00 $US | — |
| MNOV | MEDICINOVA, INC. | D- | 71,2M $US | 1,39 $US | — | 935,7K $US | -1 127,0 % |
| OKYO | OKYO Pharma Limited | non notée | 69,8M $US | 1,33 $US | — | — | — |
| FBIO | Fortress Biotech, Inc. | B | 69,7M $US | 1,88 $US | — | 70M $US | 143,0 % |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | non notée | 69,7M $US | 3,38 $US | — | — | — |
| JAGX | Jaguar Health, Inc. | C | 69,4M $US | 0,40 $US | — | 27,8M $US | -132,2 % |
| TLSA | Tiziana Life Sciences Ltd | non notée | 68,1M $US | 0,57 $US | — | — | — |
| CSBR | CHAMPIONS ONCOLOGY, INC. | D- | 67,9M $US | 4,88 $US | — | 60,7M $US | -1,8 % |
| GOSS | GOSSAMER BIO, INC. | B | 67M $US | 10,95 $US | — | 78,4M $US | -159,5 % |
| CING | Cingulate Inc. | non notée | 64,9M $US | 4,34 $US | — | — | — |
| MIST | Milestone Pharmaceuticals Inc. | non notée | 64,8M $US | 0,52 $US | — | — | — |
| CGTX | Cognition Therapeutics, Inc. | non notée | 63,8M $US | 0,67 $US | — | — | — |
| ACRV | Acrivon Therapeutics, Inc. | non notée | 62,1M $US | 1,45 $US | — | — | — |
| MAIA | MAIA BIOTECHNOLOGY, INC. | non notée | 61,8M $US | 1,00 $US | — | — | — |
| ETRA | Electra Therapeutics, Inc. | non notée | 61,7M $US | 8,96 $US | — | — | — |
| VRCA | Verrica Pharmaceuticals Inc. | D- | 61,5M $US | 3,58 $US | — | 22,9M $US | -189,2 % |
| CNXU | CONEXEU SCIENCES INC. | non notée | 61,5M $US | 2,18 $US | — | — | — |
| XBIT | XBIOTECH INC. | non notée | 59,5M $US | 1,95 $US | — | — | — |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | D- | 59,3M $US | 0,31 $US | — | 148,2M $US | -14,5 % |
| BOLD | BOUNDLESS BIO, INC. | non notée | 59M $US | 2,50 $US | — | — | — |
| TNXP | TONIX PHARMACEUTICALS HOLDING CORP. | D- | 58,5M $US | 3,01 $US | — | 43M $US | -420,4 % |
| CLGN | CollPlant Biotechnologies Ltd | D- | 58,4M $US | 4,56 $US | — | 318K $US | -4 130,2 % |
| SPRO | SPERO THERAPEUTICS, INC. | F- | 57,8M $US | 0,99 $US | — | 41,6M $US | -71,0 % |
| XLO | Xilio Therapeutics, Inc. | D- | 57,6M $US | 8,16 $US | — | 55M $US | -20,9 % |
| CRDF | CARDIFF ONCOLOGY, INC. | F- | 56,6M $US | 0,73 $US | — | 559K $US | -6 735,2 % |
| ANVS | Annovis Bio, Inc. | F | 56,4M $US | 0,91 $US | — | 0,00 $US | — |
| CLNN | Clene Inc. | C | 56,3M $US | 3,91 $US | — | 238K $US | -11 271,4 % |
| AZR | Azora Therapeutics, Inc. (DE) | non notée | 56,1M $US | 3,93 $US | — | — | — |
| NRSN | NeuroSense Therapeutics Ltd. | non notée | 53,1M $US | 1,63 $US | — | — | — |
| ELOX | ELOXX PHARMACEUTICALS, INC. | D | 51,9M $US | 12,87 $US | 1,53 | 0,00 $US | — |
| ATNM | Actinium Pharmaceuticals, Inc. | D+ | 51,6M $US | 1,64 $US | 4,56 | 90K $US | 12 564,4 % |
| RNXT | RENOVORX, INC. | D- | 50,4M $US | 1,05 $US | — | 2,8M $US | -469,0 % |
| ONCY | ONCOLYTICS BIOTECH INC. | non notée | 50,2M $US | 0,37 $US | — | — | — |
| MREO | MEREO BIOPHARMA GROUP PLC | C | 49M $US | 0,31 $US | — | 500K $US | -5 387,6 % |
| PDSB | PDS Biotechnology Corporation | non notée | 48,5M $US | 0,87 $US | — | — | — |
| INKT | MiNK Therapeutics, Inc. | non notée | 48,3M $US | 9,41 $US | — | — | — |
| HYFT | MindWalk Holdings Corp. | C- | 48,1M $US | 1,03 $US | — | 20,1M $US | -43,6 % |
| HOWL | WEREWOLF THERAPEUTICS, INC. | non notée | 47,6M $US | 0,98 $US | — | — | — |
| RNTX | Rein Therapeutics, Inc. | F | 46,9M $US | 0,54 $US | — | 0,00 $US | — |
| GANX | GAIN THERAPEUTICS, INC | non notée | 46,3M $US | 1,04 $US | — | — | — |
| DWTX | Dogwood Therapeutics, Inc. | non notée | 44,3M $US | 1,16 $US | — | — | — |
| IBO | Impact BioMedical, INC. | A | 44,2M $US | 5,11 $US | — | 38K $US | 4 247,4 % |
| PLRX | PLIANT THERAPEUTICS, INC. | D | 43,2M $US | 0,70 $US | — | 0,00 $US | — |
| IMA | ImageneBio, Inc. | C- | 43,1M $US | 3,46 $US | — | 800K $US | -5 415,6 % |
| CNTB | Connect Biopharma Holdings Limited | C- | 42,6M $US | 0,68 $US | — | 3M $US | -2 336,3 % |
| BMEA | Biomea Fusion, Inc. | non notée | 42,3M $US | 0,58 $US | — | — | — |
| ELTX | Elicio Therapeutics, Inc. | non notée | 42,2M $US | 1,49 $US | — | — | — |
| TIL | Instil Bio, Inc. | C- | 41M $US | 6,05 $US | — | 9M $US | -337,7 % |
| HYPD | HYPERION DEFI, INC. | B+ | 40,1M $US | 2,59 $US | — | 1,9M $US | 2 075,4 % |
| SER | Serina Therapeutics, Inc. | D | 39,9M $US | 1,50 $US | — | 260K $US | -9 421,5 % |
| ALDX | ALDEYRA THERAPEUTICS, INC. | non notée | 39,3M $US | 0,65 $US | — | — | — |
| CRBU | Caribou Biosciences, Inc. | F- | 39,2M $US | 0,36 $US | — | 9,4M $US | -1 085,0 % |
| BRTX | BIORESTORATIVE THERAPIES, INC. | F- | 38,5M $US | 1,51 $US | — | 357,9K $US | -3 089,6 % |
| TVGN | Tevogen Inc. | non notée | 38,4M $US | 5,90 $US | — | — | — |
| GRCE | Grace Therapeutics, Inc. | non notée | 38M $US | 1,81 $US | — | — | — |
| KLRS | KALARIS THERAPEUTICS, INC. | non notée | 37,5M $US | 1,58 $US | — | — | — |
| EXOZ | EXOZYMES INC. | non notée | 36,8M $US | 3,90 $US | — | — | — |
| TELO | Telomir Pharmaceuticals, Inc. | non notée | 36,2M $US | 0,49 $US | — | — | — |
| OSTX | OS THERAPIES INCORPORATED | non notée | 34,4M $US | 0,75 $US | — | — | — |
| INMB | INMUNE BIO INC. | D- | 32,5M $US | 1,05 $US | — | 50K $US | -33 332,0 % |
| NNVC | NANOVIRICIDES, INC. | F | 31,5M $US | 1,24 $US | — | 0,00 $US | — |
| PMN | PROMIS NEUROSCIENCES INC. | non notée | 29,6M $US | 3,29 $US | — | — | — |
| BCTX | BRIACELL THERAPEUTICS CORP. | non notée | 29,3M $US | 3,35 $US | — | — | — |
| AARD | AARDVARK THERAPEUTICS, INC. | F | 29,1M $US | 1,33 $US | — | 0,00 $US | — |
| PTHS | Pelthos Therapeutics Inc. | D- | 28,6M $US | 7,29 $US | — | 51,3M $US | -152,2 % |
| NXTC | NextCure, Inc. | non notée | 28,6M $US | 6,24 $US | — | — | — |
| IMMP | Immutep Limited | D- | 26,9M $US | 3,65 $US | — | 7,3M $US | -594,6 % |
| GRDX | GridAI Technologies Corp. | F- | 26,7M $US | 3,74 $US | — | 36,3K $US | -56 864,0 % |
| MGX | Metagenomi Therapeutics, Inc. | F- | 26,4M $US | 0,70 $US | — | 22,3M $US | -421,8 % |
| ALGS | Aligos Therapeutics, Inc. | F- | 26,3M $US | 2,11 $US | — | 5,8M $US | -1 137,2 % |
| ACET | Adicet Bio, Inc. | non notée | 25,8M $US | 2,76 $US | — | — | — |
| CRVO | CervoMed Inc. | F- | 25,3M $US | 1,68 $US | — | 8,7K $US | -326 822,5 % |
| BYSI | BeyondSpring Inc. | D | 25,2M $US | 0,61 $US | — | 0,00 $US | — |
| LITS | Lite Strategy, Inc. | D | 25,1M $US | 0,84 $US | — | 0,00 $US | — |
| ABVC | ABVC BioPharma, Inc. | D- | 24,5M $US | 0,91 $US | — | 296K $US | -1 322,6 % |
| APRE | Aprea Therapeutics, Inc. | non notée | 23,9M $US | 0,44 $US | — | — | — |
| ENLV | Enlivex Ltd. | non notée | 22,8M $US | 1,18 $US | 0,01 | — | — |
| EVAX | Evaxion A/S | B- | 22,8M $US | 2,74 $US | — | 7,5M $US | -102,4 % |
| CVM | CEL-SCI CORPORATION | non notée | 22,3M $US | 1,27 $US | — | — | — |
| FLNA | Filana Therapeutics, Inc. | non notée | 21,4M $US | 0,43 $US | — | — | — |
| ATHE | ALTERITY THERAPEUTICS LTD | non notée | 21,2M $US | 1,99 $US | — | — | — |
| ESLA | ESTRELLA IMMUNOPHARMA, INC. | non notée | 20,9M $US | 0,48 $US | — | — | — |
| IGC | IGC PHARMA, INC. | C- | 20,7M $US | 0,18 $US | — | 1,3M $US | -560,3 % |
| CNSP | CNS Pharmaceuticals, Inc. | non notée | 20,4M $US | 2,98 $US | — | — | — |
| CELU | Celularity Inc. | D | 20,2M $US | 0,62 $US | — | 18,7M $US | -245,7 % |
| BSEM | BioStem Technologies, Inc. | non notée | 20,1M $US | 1,05 $US | — | 47,5M $US | -13,9 % |
| APLM | Apollomics Inc. | B | 19,9M $US | 18,01 $US | — | 8,5M $US | -128,7 % |
| ATOS | ATOSSA THERAPEUTICS, INC. | non notée | 19,4M $US | 1,95 $US | — | — | — |
| NRXP | NRX Pharmaceuticals, Inc. | B | 19,4M $US | 2,19 $US | — | 3,4M $US | -691,8 % |
| COCP | COCRYSTAL PHARMA, INC. | non notée | 19,4M $US | 1,01 $US | — | — | — |
| LPCN | LIPOCINE INC. | D- | 19M $US | 1,72 $US | — | 3,7M $US | -249,2 % |
| KTTA | PASITHEA THERAPEUTICS CORP. | non notée | 19M $US | 0,52 $US | — | — | — |
| EDSA | EDESA BIOTECH, INC. | non notée | 18,7M $US | 1,94 $US | — | — | — |
| PLUR | Pluri Inc. | B | 17,3M $US | 1,20 $US | — | 1,5M $US | -1 943,9 % |
| CNTX | CONTEXT THERAPEUTICS INC. | non notée | 17,1M $US | 0,19 $US | — | — | — |
| BOLT | Bolt Biotherapeutics, Inc. | F- | 15,9M $US | 6,09 $US | — | 2,5M $US | -1 034,4 % |
| TVRD | TVARDI THERAPEUTICS, INC. | F- | 15,8M $US | 1,18 $US | — | 7,6M $US | -352,1 % |
| ATYR | ATYR PHARMA, INC. | F- | 15,6M $US | 6,11 $US | — | 190K $US | -28 065,3 % |
| ALLR | Allarity Therapeutics, Inc. | C- | 15,5M $US | 0,97 $US | — | 350K $US | -4 493,7 % |
| ABOS | Acumen Pharmaceuticals, Inc. | non notée | 15,4M $US | 0,21 $US | — | — | — |
| MRKR | MARKER THERAPEUTICS, INC. | D- | 15M $US | 0,90 $US | — | 3,9M $US | -220,5 % |
| CTXR | Citius Pharmaceuticals, Inc. | non notée | 14,7M $US | 0,54 $US | — | — | — |
| KYNB | KYNTRA BIO, INC. | F | 14,6M $US | 3,60 $US | — | 4,6M $US | 3 967,8 % |
| MCRB | Seres Therapeutics, Inc. | D- | 14,2M $US | 1,39 $US | — | 2,1M $US | -2 209,6 % |
| LSTA | LISATA THERAPEUTICS, INC. | F- | 13,5M $US | 1,25 $US | — | 100K $US | -17 159,0 % |
| PASG | Passage BIO, Inc. | non notée | 13,4M $US | 4,16 $US | — | — | — |
| DYAI | DYADIC INTERNATIONAL, INC. | D- | 13,3M $US | 0,33 $US | — | 3,1M $US | -226,9 % |
| BCDA | BioCardia, Inc. | F | 13M $US | 0,86 $US | — | 0,00 $US | — |
| ONCO | Onconetix, Inc. | F- | 12,6M $US | 3,20 $US | — | 645,8K $US | -1 578,8 % |
| NIKI | Niki BioSolutions, Inc. | non notée | 12,5M $US | 1,71 $US | — | — | — |
| NCEL | NewcelX Ltd. | non notée | 12,5M $US | 2,60 $US | — | — | — |
| BIVI | BIOVIE INC. | non notée | 12,2M $US | 1,14 $US | — | — | — |
| GUTS | Fractyl Health, Inc. | F- | 12M $US | 0,91 $US | — | 0,00 $US | — |
| CLRB | Cellectar Biosciences, Inc. | non notée | 11,4M $US | 1,14 $US | — | — | — |
| PTN | PALATIN TECHNOLOGIES, INC. | B- | 11,2M $US | 6,29 $US | — | 13,2M $US | -63,6 % |
| HIND | VYOME HOLDINGS, INC. | D- | 11,2M $US | 1,59 $US | — | 153,1K $US | -2 455,6 % |
| CMMB | SNOWDRIFT PARENT CORPORATION | non notée | 11,1M $US | 1,54 $US | — | — | — |
| TCRX | TSCAN THERAPEUTICS, INC. | F- | 10,9M $US | 0,16 $US | — | 5,2M $US | -2 219,2 % |
| KZIA | Kazia Therapeutics Limited. | F | 10,7M $US | 6,62 $US | 5,83 | 29,5K $US | -54 287,3 % |
| INTS | INTENSITY THERAPEUTICS, INC. | non notée | 10M $US | 3,03 $US | — | — | — |
| DARE | Dare Bioscience, Inc. | C- | 9,9M $US | 0,65 $US | — | 1,4M $US | -804,4 % |
| GDTC | CytoMed Therapeutics Limited | D- | 9,6M $US | 0,81 $US | — | 253,7K $US | -1 227,1 % |
| ICU | SeaStar Medical Holding Corp | D- | 9,3M $US | 0,82 $US | — | 2,2M $US | -678,2 % |
| CNSY | CERENOME, INC. | F- | 9,2M $US | 0,94 $US | — | 3,5M $US | -859,5 % |
| INAB | IN8BIO, INC. | non notée | 9M $US | 0,84 $US | — | — | — |
| RADX | Radiopharm Theranostics Limited | F- | 8,9M $US | 0,75 $US | — | 3,6M $US | -1 055,3 % |
| MTVA | METAVIA INC. | non notée | 8,7M $US | 1,29 $US | — | — | — |
| MBRX | Moleculin Biotech, Inc. | D | 8,7M $US | 8,16 $US | — | 0,00 $US | — |
| CALC | CalciMedica, Inc. | non notée | 8,3M $US | 1,21 $US | — | — | — |
| VTGN | VISTAGEN THERAPEUTICS, INC. | F- | 8,3M $US | 0,18 $US | — | 2,4M $US | -2 474,5 % |
| ENSC | ENSYSCE BIOSCIENCES, INC. | F- | 8,1M $US | 0,42 $US | — | 6,2M $US | -1 470,4 % |
| AEON | AEON Biopharma, Inc. | non notée | 7,8M $US | 0,16 $US | — | — | — |
| CURX | Curanex Pharmaceuticals Inc | non notée | 7,5M $US | 4,79 $US | — | — | — |
| SNGX | SOLIGENIX, INC. | non notée | 7,5M $US | 0,32 $US | — | — | — |
| TPST | Tempest Therapeutics, Inc. | non notée | 7,4M $US | 0,37 $US | — | — | — |
| ACTU | Actuate Therapeutics, Inc. | non notée | 7M $US | 0,29 $US | — | — | — |
| IMRN | IMMURON LIMITED | D- | 6,9M $US | 0,86 $US | — | 5,1M $US | -71,6 % |
| ENVB | ENVERIC BIOSCIENCES, INC. | non notée | 6,8M $US | 1,51 $US | — | — | — |
| TOVX | THERIVA BIOLOGICS, INC. | non notée | 6,6M $US | 0,14 $US | — | — | — |
| XCUR | EXICURE, INC. | F | 6,5M $US | 1,00 $US | — | 0,00 $US | — |
| FBLG | FibroBiologics, Inc. | non notée | 6,4M $US | 0,97 $US | — | — | — |
| CDIO | Cardio Diagnostics Holdings, Inc. | B- | 6,2M $US | 2,09 $US | — | 15,2K $US | -42 721,9 % |
| ALZN | ALZAMEND NEURO, INC. | non notée | 6M $US | 1,25 $US | — | — | — |
| AIM | AIM IMMUNOTECH INC. | F | 5,8M $US | 0,14 $US | — | 91K $US | -15 526,4 % |
| ACXP | Acurx Pharmaceuticals, Inc. | non notée | 5,8M $US | 0,95 $US | — | — | — |
| MTNB | MATINAS BIOPHARMA HOLDINGS, INC. | non notée | 5,6M $US | 0,88 $US | — | — | — |
| BLRX | BioLineRx Ltd | C- | 5,6M $US | 1,28 $US | — | 1,4M $US | -145,5 % |
| LTRN | LANTERN PHARMA INC. | non notée | 5,5M $US | 0,43 $US | — | — | — |
| KPRX | KIORA PHARMACEUTICALS, INC. | D | 5,5M $US | 1,24 $US | — | 0,00 $US | — |
| CVKD | Cadrenal Therapeutics, Inc. | non notée | 5,4M $US | 1,51 $US | — | — | — |
| PCSA | Processa Pharmaceuticals, Inc. | non notée | 5,3M $US | 1,90 $US | — | — | — |
| CMND | Clearmind Medicine Inc. | non notée | 5,2M $US | 4,46 $US | — | — | — |
| SKYE | Skye Bioscience, Inc. | non notée | 5M $US | 1,14 $US | — | — | — |
| ADXN | Addex Therapeutics Ltd | D- | 4,9M $US | 3,98 $US | — | 36,4K $US | -22 448,4 % |
| PULM | Pulmatrix, Inc. | C- | 4,6M $US | 1,26 $US | — | 7,8M $US | -51,4 % |
| SNTI | Senti Biosciences Holdings, Inc. | F- | 4,4M $US | 0,14 $US | — | 55K $US | -90 116,4 % |
| XTLB | XTL BIOPHARMACEUTICALS LTD. | F | 4,2M $US | 1,77 $US | — | 451K $US | -1 545,2 % |
| TCRT | Alaunos Therapeutics, Inc. | D- | 4,1M $US | 1,63 $US | — | 3K $US | -133 666,7 % |
| CELZ | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | D- | 4M $US | 0,53 $US | — | 3K $US | -249 160,1 % |
| XBIO | XENETIC BIOSCIENCES, INC. | F- | 4M $US | 1,71 $US | — | 3M $US | -123,7 % |
| TRAW | Traws Pharma, Inc. | D- | 4M $US | 0,26 $US | — | 2,8M $US | -773,0 % |
| GRI | GRI Bio, Inc. | non notée | 4M $US | 1,82 $US | — | — | — |
| SILO | SILO PHARMA, INC. | D- | 3,9M $US | 1,83 $US | — | 36,1K $US | -10 319,0 % |
| AZTR | Azitra, Inc. | F- | 3,8M $US | 0,62 $US | — | 0,00 $US | — |
| IMNN | Imunon, Inc. | non notée | 3,7M $US | 0,58 $US | — | — | — |
| PHIO | Phio Pharmaceuticals Corp | non notée | 3,7M $US | 0,77 $US | — | — | — |
| AGMB | AgomAb Therapeutics NV | non notée | 3,4M $US | 6,27 $US | — | — | — |
| MBIO | MUSTANG BIO, INC. | non notée | 3,4M $US | 0,45 $US | — | — | — |
| ERNA | Ernexa Therapeutics Inc. | non notée | 3,1M $US | 1,85 $US | — | — | — |
| EVGN | EVOGENE LTD. | F | 3,1M $US | 0,36 $US | — | 1,3M $US | -551,3 % |
| REVB | REVELATION BIOSCIENCES, INC. | non notée | 2,9M $US | 4,28 $US | — | — | — |
| DRMA | DERMATA THERAPEUTICS, INC. | non notée | 2,9M $US | 0,59 $US | — | — | — |
| GNPX | Genprex, Inc. | non notée | 2,8M $US | 2,09 $US | — | — | — |
| VIVS | VivoSim Labs, Inc. | C | 2,5M $US | 0,13 $US | — | 135K $US | -7 605,9 % |
| VRAX | Virax Biolabs Group Ltd | C- | 2,3M $US | 0,63 $US | — | 6,3K $US | -95 739,2 % |
| CLDI | Calidi Biotherapeutics, Inc. | non notée | 2,2M $US | 0,63 $US | — | — | — |
| KAPA | KAIROS PHARMA, LTD. | non notée | 2,2M $US | 0,46 $US | — | — | — |
| PPCB | PROPANC BIOPHARMA, INC. | non notée | 2M $US | 1,95 $US | — | — | — |
| ARTL | ARTELO BIOSCIENCES, INC. | non notée | 2M $US | 2,18 $US | — | — | — |
| ELAB | PMGC HOLDINGS INC. | D- | 1,9M $US | 1,63 $US | — | 4,8M $US | -275,7 % |
| CRIS | CURIS INC | F- | 1,9M $US | 0,44 $US | — | 4,3M $US | -499,4 % |
| SXTP | 60 DEGREES PHARMACEUTICALS, INC. | D- | 1,8M $US | 0,50 $US | — | 1,1M $US | -729,9 % |
| JUNS | JUPITER NEUROSCIENCES, INC. | F | 1,8M $US | 2,28 $US | — | 21,8K $US | -42 206,9 % |
| PBM | PSYENCE BIOMEDICAL LTD | non notée | 1,7M $US | 3,16 $US | — | — | — |
| HCWB | HCW Biologics Inc. | B- | 1,6M $US | 0,86 $US | — | 6,7M $US | -83,8 % |
| SCNI | SCINAI IMMUNOTHERAPEUTICS LTD. | B- | 1,4M $US | 0,41 $US | — | 3,1M $US | -270,9 % |
| BDRX | Biodexa Pharmaceuticals PLC | non notée | 1,3M $US | 2,39 $US | — | — | — |
| RNAZ | TRANSCODE THERAPEUTICS, INC. | non notée | 1,3M $US | 1,32 $US | — | — | — |
| CANF | Can-Fite BioPharma Ltd. | F- | 1,2M $US | 1,46 $US | — | 405K $US | -2 426,7 % |
| BBLG | Bone Biologics Corporation | non notée | 1,1M $US | 0,33 $US | — | — | — |
| APVO | Aptevo Therapeutics Inc. | non notée | 1,1M $US | 0,59 $US | — | — | — |
| GOVX | GEOVAX LABS, INC. | D | 928,3K $US | 1,71 $US | — | 0,00 $US | — |
| OGEN | ORAGENICS, INC. | non notée | 906,9K $US | 0,20 $US | — | — | — |
| DCOY | Decoy Therapeutics Inc. | non notée | 811,6K $US | 0,96 $US | — | — | — |
| HLSQ | BiomX Inc. | non notée | 739,4K $US | 0,07 $US | — | — | — |
| QNRX | Quoin Pharmaceuticals, Ltd. | non notée | 669,6K $US | 3,81 $US | — | — | — |
| LABT | Lakewood-Amedex Biotherapeutics Inc. | non notée | 658,5K $US | 0,28 $US | — | — | — |
| EDVA | Endovia Health Sciences, Inc. | D | 542,2K $US | 0,18 $US | — | 32,1K $US | -53 856,5 % |
| PLRZ | Polyrizon Ltd. | non notée | 508,2K $US | 11,21 $US | 2,29 | — | — |
| VBIO | Valion Bio, Inc. | F- | 461,2K $US | 0,52 $US | — | 482K $US | -3 890,0 % |
| SRZN | Surrozen, Inc./DE | D | 370,9K $US | 31,50 $US | — | 10,5M $US | -3 706,4 % |
| SLXN | SILEXION THERAPEUTICS CORP | non notée | 363,4K $US | 1,97 $US | — | — | — |
| LGVN | LONGEVERON INC. | F- | 339,1K $US | 2,45 $US | — | 1,2M $US | -1 921,7 % |
| CDT | CDT EQUITY INC. | non notée | 307,4K $US | 0,39 $US | — | — | — |
| SPRC | SCISPARC LTD. | F- | 132,6K $US | 0,36 $US | — | 679K $US | -1 793,7 % |
| NEUP | Neuphoria Therapeutics Inc. | F- | 76,2K $US | 2,54 $US | — | 1,2M $US | -1 145,7 % |
| EYPT | EyePoint, Inc. | F- | 27,6K $US | 0,31 $US | — | 2,6M $US | -13 281,2 % |
| KALA | KALA BIO, INC. | F | 10,1K $US | 0,14 $US | — | 0,00 $US | — |
| KPTI | Karyopharm Therapeutics Inc. | C | 503,52 $US | 0,02 $US | — | 146,6M $US | -153,3 % |
| PPBT | PURPLE BIOTECH LTD. | non notée | 370,84 $US | 1,55 $US | — | — | — |
| QNTM | Quantum BioPharma Ltd. | non notée | 19,50 $US | 1,63 $US | — | — | — |
| APGE | Apogee Therapeutics, Inc. | non notée | — | 135,07 $US | — | — | — |
| ATAI | AtaiBeckley Inc. | non notée | — | 7,35 $US | — | 4,1M $US | -16 142,0 % |
| BCAB | BIOATLA, INC. | non notée | — | 1,74 $US | — | — | — |
| BRNS | BARINTHUS BIOTHERAPEUTICS PLC | D- | — | 0,74 $US | — | 0,00 $US | — |
| CRNX | Crinetics Pharmaceuticals, Inc. | D- | — | 84,95 $US | — | 42,2M $US | -1 189,9 % |
| FBRX | FORTE BIOSCIENCES, INC. | non notée | — | 76,99 $US | — | — | — |
| LNAI | LUNAI BIOWORKS INC. | B | — | 0,16 $US | — | 52K $US | -6 852,0 % |
| MLEC | MOOLEC SCIENCE SA | B | — | 0,85 $US | — | 333,6M $US | -52,9 % |
| MOLN | MOLECULAR PARTNERS AG | F | — | 3,22 $US | — | 0,00 $US | — |
| OSRH | OSR HEALTH, INC. | D- | — | 0,12 $US | — | 1,7M $US | -781,5 % |
| SLBT | SL Science Holding Ltd | non notée | — | 0,75 $US | — | — | — |
| TBPH | Theravance Biopharma, Inc. | C | — | 17,03 $US | — | 104,3M $US | 51,6 % |
| VCRE | Vicore Pharma Holding AB | non notée | — | 10,63 $US | — | — | — |
| VRXA | Veraxa Biotech Holding AG | non notée | — | 1,12 $US | — | — | — |
| VTVT | vTv Therapeutics Inc. | C- | — | 19,52 $US | — | 36,8M $US | -20,8 % |
Fondamentaux issus des documents déposés auprès de la SEC, cours issus de la dernière collecte de données de marché. Triez par n’importe quelle colonne ; les entreprises sans chiffre passent en dernier dans les deux sens.
Trié par capitalisation, de la plus grande à la plus petite ; cliquez sur une colonne pour retrier. Les entreprises sans chiffre passent en dernier dans les deux sens, parce qu’un PER manquant signifie une perte et non un titre bon marché. Rien ici n’est une recommandation.